
The U.S. Food and Drug Administration (FDA) has approved Xolair, a medication initially designed for asthma, to be used in the treatment of food allergies to prevent severe reactions. The approval extends to patients as young as one-year-old.
According to a Centers for Disease Control and Prevention (CDC) report, around 8% of children in the United States have a food allergy. Food allergies can manifest in the form of symptoms such as digestive problems, hives or swollen airways. In some people, exposure to allergenic foods can result in potentially life-threatening reactions, commonly referred to as anaphylaxis.